Tactic Pharma LLC 13D and 13G filings for Monopar Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-30 2:32 pm Sale | 2026-01-28 | 13D | Monopar Therapeutics Inc. MNPR | Tactic Pharma LLC | 307,370 4.500% | -198,829 (-39.28%) | Filing |
| 2025-09-24 8:59 pm Sale | 2025-09-24 | 13D | Monopar Therapeutics Inc. MNPR | Tactic Pharma LLC | 506,199 7.500% | -531,197 (-51.20%) | Filing |
| 2024-12-17 5:01 pm Purchase | 2024-12-09 | 13D | Monopar Therapeutics Inc. MNPR | Tactic Pharma LLC | 1,037,396 19.200% | 1,037,396 (New Position) | Filing |